SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 200 filers reported holding SAGE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,000 | 0.0% | 81 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 81 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 81 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 81 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -85.0% | 81 | -80.5% | 0.00% | – |
| Q4 2018 | $40,000 | -25.9% | 416 | +8.9% | 0.00% | – |
| Q3 2018 | $54,000 | -61.7% | 382 | -83.1% | 0.00% | -100.0% |
| Q3 2017 | $141,000 | -91.6% | 2,263 | -93.1% | 0.00% | -87.5% |
| Q4 2016 | $1,673,000 | +10.5% | 32,764 | -0.3% | 0.01% | 0.0% |
| Q3 2016 | $1,514,000 | +53.1% | 32,865 | +0.1% | 0.01% | +60.0% |
| Q2 2016 | $989,000 | -8.8% | 32,828 | -3.0% | 0.01% | -16.7% |
| Q1 2016 | $1,085,000 | -43.3% | 33,849 | +3.1% | 0.01% | -45.5% |
| Q4 2015 | $1,914,000 | +37.7% | 32,830 | -0.0% | 0.01% | +37.5% |
| Q3 2015 | $1,390,000 | +34.8% | 32,831 | +132.4% | 0.01% | +60.0% |
| Q2 2015 | $1,031,000 | +51450.0% | 14,128 | +33538.1% | 0.01% | – |
| Q1 2015 | $2,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |